Physiopathology of Pulmonary Arterial Hypertension: Mechanistic Studies
NCT02959723 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2016-11-09
Summary
The current aims to combine analysis of different inflammatory biomarkers and BMPR2 mutations, which are currently analyzed in each patient diagnosed with idiopathic or familial PAH, to establish an earlier diagnosis and consequently better orientate the therapeutic strategy in PAH.
Conditions
- Idiopathic Pulmonary Arterial Hypertension
Sponsors & Collaborators
-
Universitaire Ziekenhuizen KU Leuven
lead OTHER
Eligibility
- Min Age
- 15 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-01-31
- Primary Completion
- 2017-12-31
- Completion
- 2020-12-31
Countries
- Belgium
Study Locations
More Related Trials
-
Correlation OF Hemodynamics in Pulmonary Hypertension With Perfusion Lung Scans
NCT00621075 ·Status: COMPLETED
-
Longitudinal Study to Identify Predictive Factors of Post-thrombotic Pulmonary Hypertension
NCT03134898 ·Status: COMPLETED
-
Endothelial Cell Dysfunction in Pulmonary Hypertension
NCT00098072 ·Status: COMPLETED ·Phase: PHASE1
-
Rt Ventricular Substrate Metabolism as a Predictor of Rt Heart Failure in Patients With Pulmonary Arterial Hypertension
NCT01572077 ·Status: COMPLETED ·Phase: NA
-
Predictors of Pulmonary Hypertension in Patients With Advanced Lung Diseases
NCT02777957 ·Status: UNKNOWN
-
Serum Bio-markers in Pulmonary Hypertension
NCT04472533 ·Status: COMPLETED
-
Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography
NCT01829672 ·Status: COMPLETED ·Phase: NA
-
Validation of a Machine Learning Predictive Model to Distinguish Post-capillary Pulmonary Hypertension
NCT06405126 ·Status: RECRUITING
-
Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography
NCT01607489 ·Status: COMPLETED ·Phase: NA
-
Gene Mutations in Secondary Pulmonary Hypertension
NCT00348803 ·Status: UNKNOWN
-
Phase-II Study of the Use of PulmoBind for Molecular Imaging of Pulmonary Hypertension
NCT02216279 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Registry and Biobank for Long-term Observational Studies in Adult Patients with Pulmonary Hypertension
NCT04654650 ·Status: RECRUITING
-
Clinical, Radiological, Tissue and Biological Phenotyping for the Analysis of the Transition From Physiology to Pathology in Pulmonary Diseases With Pulmonary Hypertension
NCT07184671 ·Status: NOT_YET_RECRUITING
-
Endothelial Progenitor Cells and Pulmonary Idiopathic Arterial Hypertension
NCT00551408 ·Status: COMPLETED
-
Evaluation of Latent Pulmonary Arterial Hypertension in Congenital Shunt Lesions
NCT02552485 ·Status: COMPLETED
-
A Pilot Study Evaluating Heart and Lung Metabolism in Pulmonary Hypertension Associated With Left Heart Disease
NCT02237378 ·Status: TERMINATED ·Phase: NA
-
Multi-marker Approach for Risk Assessment in PAH
NCT03954405 ·Status: RECRUITING
-
Early Recognition of Pulmonary Arterial Hypertension in Myelodysplastic and Myeloproliferative Diseases
NCT00909467 ·Status: COMPLETED
-
Pulmonary Hypertension Association Registry
NCT04071327 ·Status: RECRUITING
-
Prognostic Value of Estimated Plasma Volume in Pulmonary Hypertension
NCT05861479 ·Status: COMPLETED
-
Screening for Pulmonary Vascular Changes in Patients With Chronic Myeloproliferative Diseases
NCT01787162 ·Status: COMPLETED
-
Volatile Organic Compounds (VOCs) as a Biomarker in Immune-mediated Pulmonary Arterial Hypertension (PAH)
NCT03819777 ·Status: UNKNOWN
-
3D Imaging: Prognostic Role in Pulmonary Arterial Hypertension
NCT02799979 ·Status: UNKNOWN
-
Non-Invasive Measurement of Cardiac Output and Stroke Volume in PAH/CTEPH
NCT05618093 ·Status: WITHDRAWN ·Phase: NA
-
Differential Diagnosis of Pulmonary Hypertension With Automated Image Analysis
NCT04329312 ·Status: TERMINATED